Biogen Inc
Change company Symbol lookup
Select an option...
BIIB Biogen Inc
GTY Getty Realty Corp
FCX Freeport-McMoRan Inc
EFX Equifax Inc
CHKP Check Point Software Technologies Ltd
CTXS Citrix Systems Inc
RAKR Rainmaker Worldwide Inc
CLB Core Laboratories NV
KERN Akerna Corp
T AT&T Inc
Go

Health Care : Biotechnology | Large Cap Value
Company profile

Biogen Inc. is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA and FAMPYRA for multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA). It also has a collaboration agreement with Genentech, Inc. (Genentech), a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other anti-CD20 therapies. The Company's product candidate includes OCREVUS; Biosimilar adalimumab; Aducanumab; E2609; BIIB074; BAN2401; Opicinumab; CIRARA; BIIB061; BIIB054; BIIB067, and BIIB068.

Price
Delayed
$266.21
Day's Change
-2.70 (-1.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
269.19
Day's Low
264.86
Volume
(Heavy Day)

Today's volume of 382,136 shares is on pace to be much greater than BIIB's 10-day average volume of 1,015,075 shares.

382,136
  • Prev Close
    268.91
  • Today's Open
    264.99
  • Day's Range
    264.86-269.19
  • Avg Vol (10-day)
    1.0M
  • Last (time)
    11:07a ET 10/22/20
  • Last (size)
    103
  • 52-Wk Range
    257.60 - 374.99
    LowHigh
  • (02/05/20 - 06/26/20)
    3.34%
  • 44.1%
  • Market Cap
    42.2B
  • Shares Outstanding
    158.3M
  • --
  • --x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • --
  • --

Latest News

October 22, 2020
7:28 am ET
MarketWatch
October 21, 2020
2:14 pm ET
MarketWatch
7:28 am ET
MarketWatch
7:26 am ET
MarketWatch
7:26 am ET
MarketWatch
7:25 am ET
MarketWatch
7:25 am ET
MarketWatch
7:24 am ET
MarketWatch
October 20, 2020
11:39 am ET
PR Newswire
October 06, 2020
10:00 am ET
BusinessWire
7:00 am ET
Globe Newswire
September 28, 2020
8:07 am ET
PR Newswire
September 14, 2020
7:30 am ET
Globe Newswire
September 11, 2020
8:02 am ET
Globe Newswire
September 08, 2020
7:44 am ET
Globe Newswire
September 03, 2020
2:14 pm ET
PR Newswire
August 25, 2020
9:00 am ET
PR Newswire
August 08, 2020
10:40 am ET
MarketWatch
August 07, 2020
8:55 am ET
MarketWatch
7:30 am ET
Globe Newswire
August 06, 2020
9:13 am ET
MarketWatch
8:03 am ET
Globe Newswire
August 04, 2020
9:00 am ET
PR Newswire
July 27, 2020
11:16 am ET
MarketWatch
July 24, 2020
4:15 pm ET
Globe Newswire
July 22, 2020
7:30 am ET
MarketWatch
7:24 am ET
MarketWatch
7:24 am ET
MarketWatch
7:23 am ET
MarketWatch
7:23 am ET
MarketWatch
7:22 am ET
MarketWatch
7:22 am ET
MarketWatch
7:21 am ET
MarketWatch
7:21 am ET
MarketWatch
7:21 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.